Cisplatin is retained in the cochlea indefinitely following chemotherapy
Sign Up to like & getrecommendations! Published in 2017 at "Nature Communications"
DOI: 10.1038/s41467-017-01837-1
Abstract: Cisplatin chemotherapy causes permanent hearing loss in 40–80% of treated patients. It is unclear whether the cochlea has unique sensitivity to cisplatin or is exposed to higher levels of the drug. Here we use inductively… read more here.
Keywords: chemotherapy; cisplatin retained; cisplatin; cochlea ... See more keywords